A genome-wide genetic pleiotropy approach identified shared loci between multiple system atrophy and inflammatory bowel disease
暂无分享,去创建一个
Sonja W. Scholz | A. Singleton | C. Gieger | O. Andreassen | M. Nöthen | Mary B Makarious | C. Blauwendraat | J. Hardy | C. Schmidt | O. Rascol | W. Lieb | S. Schreiber | M. Müller-Nurasyid | W. Meissner | G. Homuth | A. Franke | D. Ellinghaus | A. Arnold | T. Gasser | S. Scholz | J. R. Gibbs | P. Hoffmann | G. Wenning | Antonio Heras-Garvin | N. Stefanova | H. Houlden | Manu Sharma | S. Mucha | A. Shadrin | S. Bahrami | O. Frei | A. Foubert-Samier | Jinhui Ding | K. O’Connell | A. P. Traon | Monia Hammer | A. A. Sreelatha | S. Schreiber | M. Hammer | M. Sharma | A. Traon | J. Hardy | Sören Mucha
[1] Judy H. Cho,et al. Finding the missing heritability of complex diseases , 2009, Nature.
[2] Timothy J. Hohman,et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.
[3] Nicola J. Rinaldi,et al. Genetic effects on gene expression across human tissues , 2017, Nature.
[4] P. Visscher,et al. 10 Years of GWAS Discovery: Biology, Function, and Translation. , 2017, American journal of human genetics.
[5] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[6] Kevin L. Boehme,et al. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case–control study , 2017, PLoS medicine.
[7] W. Spooren,et al. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. , 2002, EMBO reports.
[8] Evan Z. Macosko,et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.
[9] H. Stefánsson,et al. Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease , 2015, Circulation.
[10] M. Nalls,et al. Establishing the role of rare coding variants in known Parkinson's disease risk loci , 2017, Neurobiology of Aging.
[11] E. M. De La Cruz,et al. Insights regarding guanine nucleotide exchange from the structure of a DENN-domain protein complexed with its Rab GTPase substrate , 2011, Proceedings of the National Academy of Sciences.
[12] M. Daly,et al. Searching for missing heritability: Designing rare variant association studies , 2014, Proceedings of the National Academy of Sciences.
[13] Judy H. Cho,et al. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease , 2018, Science Translational Medicine.
[14] Thawfeek M. Varusai,et al. The Reactome Pathway Knowledgebase , 2017, Nucleic acids research.
[15] O. Andreassen,et al. Boosting the power of schizophrenia genetics by leveraging new statistical tools. , 2014, Schizophrenia bulletin.
[16] Howard Y. Chang,et al. Lineage-specific and single cell chromatin accessibility charts human hematopoiesis and leukemia evolution , 2016, Nature Genetics.
[17] J. Hirschhorn,et al. Biological interpretation of genome-wide association studies using predicted gene functions , 2015, Nature Communications.
[18] M. Tansey,et al. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? , 2017, npj Parkinson's Disease.
[19] P. Deloukas,et al. Multiple common variants for celiac disease influencing immune gene expression , 2010, Nature Genetics.
[20] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[21] Brittany N. Lasseigne,et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.
[22] J. Nutt,et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.
[23] W. Poewe,et al. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies , 2018, Acta Neuropathologica Communications.
[24] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[25] Xihong Lin,et al. The effect of correlation in false discovery rate estimation. , 2011, Biometrika.
[26] Helen Schuilenburg,et al. Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.
[27] Erdogan Taskesen,et al. Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.
[28] Emily Dimmer,et al. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology , 2004, Nucleic Acids Res..
[29] Shuang Feng,et al. RAREMETAL: fast and powerful meta-analysis for rare variants , 2014, Bioinform..
[30] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[31] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[32] G. Guillemin,et al. Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation , 2015, Front. Cell. Neurosci..
[33] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[34] Sina A. Gharib,et al. Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.
[35] M. McCarthy,et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. , 2013, American journal of human genetics.
[36] K. Jellinger,et al. Neuropathological spectrum of synucleinopathies , 2003, Movement disorders : official journal of the Movement Disorder Society.
[37] Nicholas W Wood,et al. Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases , 2017, JAMA neurology.
[38] J. Trojanowski,et al. Is multiple system atrophy an infectious disease? , 2018, Annals of neurology.
[39] O. Blin,et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy , 1994, Journal of the Neurological Sciences.
[40] Sonja W. Scholz,et al. A genome-wide association study in multiple system atrophy , 2016, Neurology.
[41] Chuong B. Do,et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.
[42] S. Mallal,et al. T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.
[43] Sina A. Gharib,et al. Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis , 2018, bioRxiv.
[44] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[45] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[46] Lilah M. Besser,et al. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.
[47] O. Andreassen,et al. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[48] C. Wijmenga,et al. Gene expression analysis identifies global gene dosage sensitivity in cancer , 2015, Nature Genetics.
[49] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[50] Yakir A Reshef,et al. Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.
[51] A Smith,et al. Genetic overlap between Alzheimer’s disease and Parkinson’s disease at the MAPT locus , 2015, Molecular Psychiatry.
[52] Xihong Lin,et al. Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.
[53] Michael J. Gloudemans,et al. Abundant associations with gene expression complicate GWAS follow-up , 2019, Nature Genetics.
[54] Rena Li,et al. What does complement do in Alzheimer’s disease? Old molecules with new insights , 2013, Translational Neurodegeneration.
[55] D. Rujescu,et al. Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate , 2013, PLoS genetics.
[56] Andrew J. Lees,et al. Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy , 2011, Nature Genetics.
[57] E. Masliah,et al. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy , 2015, Molecular Neurodegeneration.
[58] Alexander Gerhard,et al. Frontotemporal dementia and its subtypes: a genome-wide association study , 2014, The Lancet Neurology.
[59] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[60] Jun S. Liu,et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .
[61] Minoru Kanehisa,et al. New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..
[62] Günther Deuschl,et al. The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.
[63] Sonja W. Scholz,et al. SNCA variants are associated with increased risk for multiple system atrophy , 2009, Annals of neurology.
[64] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[65] Hideo Fujiwara,et al. Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes , 2002 .
[66] Eurie L. Hong,et al. Annotation of functional variation in personal genomes using RegulomeDB , 2012, Genome research.
[67] Mohamad Saad,et al. Genetic comorbidities in Parkinson's disease. , 2014, Human molecular genetics.
[68] T. Raj,et al. Early‐onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation , 2019, Movement disorders : official journal of the Movement Disorder Society.
[69] D. Hernandez,et al. Genome-wide estimate of the heritability of Multiple System Atrophy. , 2016, Parkinsonism & related disorders.
[70] B. Pakkenberg,et al. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014 , 2018, Gut.
[71] Y. Fang,et al. Complement C7 is a novel risk gene for Alzheimer's disease in Han Chinese , 2018, National science review.
[72] Mark R. Cookson,et al. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease , 2010, Nature Reviews Neuroscience.
[73] David C. Wilson,et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.
[74] M. Fornage,et al. Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation , 2018, Molecular Psychiatry.
[75] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.